Alumis (ALMS) Net Cash Flow (2023 - 2025)
Alumis (ALMS) reported Net Cash Flow of $24.4 million for Q4 2025, up 155.75% year-over-year from $9.5 million in Q4 2024, and up 128.11% quarter-over-quarter from -$86.9 million in Q3 2025.
Alumis (ALMS) Net Cash Flow (2023 - 2025) Analysis & Trends
Alumis (ALMS) has 3 years of Net Cash Flow data on file, last reported at $24.4 million in Q4 2025.
- Net Cash Flow for Q4 2025 came in at $24.4 million, up 155.75% year-over-year; the trailing twelve-month figure through Dec 2025 was -$80.3 million (down 165.04% YoY), and the FY2025 annual result was -$79.6 million, down 164.44% from the prior year.
- Net Cash Flow climbed to $24.4 million in Q4 2025 per ALMS's latest filing, from -$86.9 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $66.0 million in Q1 2024 and troughed at -$86.9 million in Q3 2025.
- A 3-year average of $939900.0 and a median of $7.4 million in 2023 frame the typical range for Net Cash Flow.
- On a YoY basis, Net Cash Flow climbed as much as 327.34% in 2024 and fell as far as 434.58% in 2024.
- A 3-year view of Net Cash Flow shows it stood at -$8.2 million in 2023, then slumped by 434.58% to -$43.8 million in 2024, then soared by 155.75% to $24.4 million in 2025.
- Business Quant data shows ALMS's Net Cash Flow at $24.4 million in Q4 2025, -$86.9 million in Q3 2025, and $23.1 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 625.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 457.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 664,983.53 |
| 10 | Alumis | 1.99 Bn | 1.90 Bn | - | 24.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 24.42 Mn |
| Dec 31, 2025 | 24.42 Mn |
| Sep 30, 2025 | -86.88 Mn |
| Sep 30, 2025 | -86.88 Mn |
| Jun 30, 2025 | 23.06 Mn |
| Jun 30, 2025 | 23.06 Mn |
| Mar 31, 2025 | -40.93 Mn |
| Mar 31, 2025 | -40.93 Mn |
| Dec 31, 2024 | -43.81 Mn |
| Dec 31, 2024 | -43.81 Mn |
| Sep 30, 2024 | 58.15 Mn |
| Sep 30, 2024 | 58.15 Mn |
| Jun 30, 2024 | 43.12 Mn |
| Jun 30, 2024 | 43.12 Mn |
| Mar 31, 2024 | 66.04 Mn |
| Mar 31, 2024 | 66.04 Mn |
| Dec 31, 2023 | -8.20 Mn |
| Dec 31, 2023 | -8.20 Mn |
| Sep 30, 2023 | -25.58 Mn |
| Sep 30, 2023 | -25.58 Mn |